Isofol Medical (Sweden) Performance
| ISOFOL Stock | SEK 0.59 0.01 1.67% |
The company retains a Market Volatility (i.e., Beta) of -0.68, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Isofol Medical are expected to decrease at a much lower rate. During the bear market, Isofol Medical is likely to outperform the market. At this point, Isofol Medical AB has a negative expected return of -0.26%. Please make sure to check out Isofol Medical's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Isofol Medical AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Isofol Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Isofol |
Isofol Medical Relative Risk vs. Return Landscape
If you would invest 70.00 in Isofol Medical AB on November 23, 2025 and sell it today you would lose (11.00) from holding Isofol Medical AB or give up 15.71% of portfolio value over 90 days. Isofol Medical AB is generating negative expected returns and assumes 2.3883% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than Isofol, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Isofol Medical Target Price Odds to finish over Current Price
The tendency of Isofol Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.59 | 90 days | 0.59 | about 98.0 |
Based on a normal probability distribution, the odds of Isofol Medical to move above the current price in 90 days from now is about 98.0 (This Isofol Medical AB probability density function shows the probability of Isofol Stock to fall within a particular range of prices over 90 days) .
Isofol Medical Price Density |
| Price |
Predictive Modules for Isofol Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Isofol Medical AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Isofol Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Isofol Medical is not an exception. The market had few large corrections towards the Isofol Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Isofol Medical AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Isofol Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | -0.68 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.1 |
Isofol Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Isofol Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Isofol Medical AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Isofol Medical AB generated a negative expected return over the last 90 days | |
| Isofol Medical AB has some characteristics of a very speculative penny stock | |
| Isofol Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 22.41 M. Net Loss for the year was (200.25 M) with loss before overhead, payroll, taxes, and interest of (174.31 M). | |
| Isofol Medical AB has accumulated about 379.45 M in cash with (188.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 26.0% of the company shares are held by company insiders |
Isofol Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Isofol Stock often depends not only on the future outlook of the current and potential Isofol Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Isofol Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 379.4 M |
Isofol Medical Fundamentals Growth
Isofol Stock prices reflect investors' perceptions of the future prospects and financial health of Isofol Medical, and Isofol Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Isofol Stock performance.
| Return On Equity | -0.69 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (13.09) % | |||
| Current Valuation | (42.41 M) | |||
| Shares Outstanding | 161.52 M | |||
| Price To Book | 0.65 X | |||
| Price To Sales | 7.45 X | |||
| Revenue | 22.41 M | |||
| EBITDA | (198.49 M) | |||
| Cash And Equivalents | 379.45 M | |||
| Cash Per Share | 0.93 X | |||
| Total Debt | 110 K | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | 1.14 X | |||
| Cash Flow From Operations | (188.43 M) | |||
| Earnings Per Share | (1.42) X | |||
| Total Asset | 401.36 M | |||
About Isofol Medical Performance
By analyzing Isofol Medical's fundamental ratios, stakeholders can gain valuable insights into Isofol Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Isofol Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Isofol Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden. Isofol Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.Things to note about Isofol Medical AB performance evaluation
Checking the ongoing alerts about Isofol Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Isofol Medical AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Isofol Medical AB generated a negative expected return over the last 90 days | |
| Isofol Medical AB has some characteristics of a very speculative penny stock | |
| Isofol Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 22.41 M. Net Loss for the year was (200.25 M) with loss before overhead, payroll, taxes, and interest of (174.31 M). | |
| Isofol Medical AB has accumulated about 379.45 M in cash with (188.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 26.0% of the company shares are held by company insiders |
- Analyzing Isofol Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Isofol Medical's stock is overvalued or undervalued compared to its peers.
- Examining Isofol Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Isofol Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Isofol Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Isofol Medical's stock. These opinions can provide insight into Isofol Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Isofol Stock analysis
When running Isofol Medical's price analysis, check to measure Isofol Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isofol Medical is operating at the current time. Most of Isofol Medical's value examination focuses on studying past and present price action to predict the probability of Isofol Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isofol Medical's price. Additionally, you may evaluate how the addition of Isofol Medical to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |